Skip to content

Profound Medical PROF Balance Sheet Statement

FY'25FY'24FY'23
$59.72M+8.8%$54.91M+109%$26.21M
$7.2M+2.2%$7.05M-3.3%$7.29M
$31.72M+464%$5.63M-16.3%$6.72M
$76.09M+10.2%$69.07M+64.8%$41.9M
$698K+64.2%$425K-53.2%$909K
$184K-53.5%$396K-40.1%$661K
$138K-47.1%$261K-46.7%$490K
$334K+1,584%-$22.5K-122%$103.25K
$77.48M+10.3%$70.23M+59.8%$43.96M
$1.56M+18.7%$1.32M+52.3%$865K
$3.82M+34.6%$2.84M+17.2%$2.42M
$445K+6.2%$419K-41.9%$721K
$1.74M-17.4%$2.1M
$213K-17.1%$257K-0.8%$259K
$388K+692%$49K-93.3%$728K
$39K
$6.08M-7.5%$6.57M+3.1%$6.37M
$4.5M+53.9%$2.92M-41.5%$5M
$203K-59.7%$504K
$213K-53.7%$460K
$79K+11.3%$71K-2.7%$73K
$11.04M+12.5%$9.81M-22.9%$12.73M
$323.84M+15.0%$281.55M+26.7%$222.21M
$25.31M+18.8%$21.3M+2.4%$20.81M
-$287.74M-17.4%-$245.17M-12.8%-$217.35M
$5.03M+83.3%$2.74M-50.7%$5.57M
$66.43M+10.0%$60.42M+93.5%$31.22M-40.6%
$77.48M+10.3%$70.23M+59.8%$43.96M
$928K-29.0%$1.31M-7.0%$1.41M
$184K-53.5%$396K-40.1%$661K
$300K
$66K-24.1%$87K
$138K-47.1%$261K-46.7%$490K
$184K-53.5%$396K-40.1%$661K
$184K-53.5%$396K-40.1%$661K
$388K+692%$49K-93.3%$728K
$445K+6.2%$419K-41.9%$721K
$388K+692%$49K-93.3%$728K
$3.82M+34.6%$2.84M+17.2%$2.42M
$388K+692%$49K-93.3%$728K
$4.71M-8.0%$5.12M-34.9%$7.87M
$323.84M+15.0%$281.55M+26.7%$222.21M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Profound Medical's total assets?
Profound Medical (PROF) holds $73.5M in total assets, up 20.7% year over year.
How much debt does Profound Medical have?
Profound Medical carries $7.5M in total debt against $59.4M of shareholders' equity, a debt-to-equity ratio of 0.13.
How much cash does Profound Medical have?
Profound Medical holds $50.3M in cash and equivalents.
Can Profound Medical cover its short-term obligations?
Its current ratio is 6.56 — current assets exceed current liabilities.
Where does Profound Medical's balance sheet data come from?
Every line is extracted from Profound Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.